What is the history of Primary ciliary dyskinesia?

Primary ciliary dyskinesia (PCD) was first clinically characterized in the early 20th century as a triad of symptoms, though it was not until the 1970s that the underlying defect in ciliary motility was identified. Understanding of Primary ciliary dyskinesia has since evolved from a purely clinical diagnosis to a complex genetic condition defined by over 40 distinct gene mutations that impair the function of motile cilia.

When and how was Primary ciliary dyskinesia first described?

The history of Primary ciliary dyskinesia dates back to 1904, when the physician A.K. Siewert first described the association between situs inversus (where internal organs are mirrored) and bronchiectasis. However, it was not until 1933 that Manes Kartagener published a landmark paper establishing the "Kartagener triad": situs inversus, chronic sinusitis, and bronchiectasis. For decades, the condition was referred to as Kartagener syndrome, though clinicians eventually realized that many patients with the same underlying respiratory issues did not have situs inversus, leading to the broader classification of Primary ciliary dyskinesia.

How did our understanding of the condition evolve?

The most significant turning point occurred in 1976, when Björn Afzelius used electron microscopy to demonstrate that the cilia in the respiratory tracts of these patients were structurally abnormal and immobile. This discovery confirmed that the disease was caused by a defect in the "dynein arms" of the cilia, which act as the engine for movement. As genetic sequencing technology advanced in the 1990s and 2000s, researchers moved beyond microscopy to identify specific genetic mutations—such as those in the DNAI1 and DNAH5 genes—that cause Primary ciliary dyskinesia. Today, we know that because cilia are present throughout the body, the disease affects not just the lungs, but also fertility and organ placement.

What were the major milestones in treatment and advocacy?

Historically, the treatment for Primary ciliary dyskinesia was focused solely on managing symptoms, often mirroring the protocols used for cystic fibrosis. There have been several key developments in the clinical approach to the disease:

• 1970s: Validation of the "immotile cilia syndrome" hypothesis.


• 1980s-90s: Implementation of aggressive airway clearance techniques and early antibiotic intervention.


• 2000s-Present: Development of standardized diagnostic guidelines, including nasal nitric oxide (nNO) testing and high-speed video microscopy.


• Patient Advocacy: The rise of global organizations has transformed the landscape for the 66 members of the DiseaseMaps community and thousands more, shifting the focus toward personalized care and the pursuit of gene-targeted therapies.

How have historical misconceptions been corrected?

In the past, many patients with Primary ciliary dyskinesia were misdiagnosed with cystic fibrosis or chronic asthma due to overlapping respiratory symptoms. The correction of these misconceptions came through the realization that Primary ciliary dyskinesia is a structural, rather than a secretory, disease. The medical community now recognizes that situs inversus is only present in approximately 50% of people with the condition, which prevents clinicians from ruling out the diagnosis based on organ placement alone.

Next steps

• Consult a pulmonologist who specializes in rare airway diseases to ensure you have had genetic testing or high-speed video microscopy.


• Engage with the DiseaseMaps.org community to share experiences and learn about regional specialists.


• Review the latest clinical guidelines from the PCD Foundation to ensure your airway clearance regimen is up-to-date.


• Reach out to a genetic counselor to understand the inheritance patterns relevant to your family.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Primary ciliary dyskinesia overview.


• Orphanet: Clinical practice guidelines for the management of Primary ciliary dyskinesia.


• OMIM (Online Mendelian Inheritance in Man): Catalog of genes associated with ciliary dyskinesia.


• PCD Foundation: Historical archives and patient education resources.